Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Surgi-Vision Founder Zerhouni Nominated For NIH Directorship

This article was originally published in The Gray Sheet

Executive Summary

Johns Hopkins University School of Medicine radiologist and Vice Dean Elias Zerhouni, MD, President Bush's choice to head the National Institutes of Health, helped found a medical technology company and has strong ties to the federal agency he has been asked by the administration to lead

You may also be interested in...



Radiologist Zerhouni Ready To Take Reins At NIH; Six More Chiefs In Waiting

Elias Zerhouni, MD, will target as one of his first priorities as National Institutes of Health director the recruitment of individuals to fill leadership spots at several NIH institutes and centers

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016353

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel